Menopause and Your Immune System: Why You Seem to Get Sick More

It does not weaken it so much as rewire it. The immune system after menopause is not simply less capable - it is differently tuned, and some of that retuning makes you more vulnerable.

The reason this happens at all is that immune cells carry estrogen receptors. T cells, B cells, natural killer cells, macrophages, and dendritic cells all express estrogen receptor alpha, estrogen receptor beta, or both. Estrogen is not just a reproductive hormone that happens to have side effects elsewhere; it is a genuine immune signalling molecule.

Before menopause, this produces a well-documented sex difference. Women mount stronger antibody responses to vaccination than men, clear many infections faster, and - the flip side - account for roughly 80% of autoimmune disease diagnoses. A more aggressive immune system is better at fighting pathogens and more prone to attacking the body's own tissue.

After menopause, several specific changes have been documented in the immunology literature:

• •Reduced naive T cell output, meaning a smaller repertoire of cells able to respond to pathogens the body has not met before
• •Altered B cell function, affecting antibody quality and durability
• •Changed natural killer cell activity, relevant to viral defence
• •Increased baseline inflammatory signalling, particularly IL-6 and TNF-alpha

That last point is the one that matters most, and it is worth its own section. But the practical summary is this: the postmenopausal immune system is somewhat slower to respond to new threats while being more inflamed at rest. It is the worst of both configurations.

Ageing does this to everyone. Menopause simply compresses several years of it into a short window.

Inflammaging is the term for the chronic, low-grade inflammation that builds up with age in the absence of any infection. It is not the acute inflammation of a sprained ankle - it is a persistent background hum of inflammatory signalling that never fully switches off.

The key markers are interleukin-6 (IL-6), tumour necrosis factor alpha (TNF-alpha), and C-reactive protein (CRP). These rise gradually across adulthood in both sexes, but in women the rise steepens around the menopause transition.

Estrogen ordinarily restrains this process. It suppresses production of IL-6 and TNF-alpha and moderates the activity of NF-kB, a master switch controlling inflammatory gene expression. When estrogen falls, that brake comes off.

Why does this matter beyond feeling generally worse? Because chronic low-grade inflammation is now implicated in most of the conditions that increase after menopause:

• •Cardiovascular disease - inflammation drives atherosclerotic plaque formation and instability
• •Osteoporosis - IL-6 and TNF-alpha directly stimulate the osteoclasts that break down bone
• •Insulin resistance - inflammatory signalling interferes with insulin's action on cells
• •Joint pain - much of the aching that appears in midlife has an inflammatory component
• •Cognitive changes - neuroinflammation is a plausible contributor to brain fog

This explains something that puzzles many women: why so many apparently unrelated symptoms arrive at once. Sore joints, poorer sleep, rising cholesterol, and a foggy head look like five separate problems. They share a common upstream driver.

It also means the interventions that lower inflammation tend to help several symptoms simultaneously - which is a rare piece of good news in menopause management. Our guide to an [anti-inflammatory diet for menopause](/blog/anti-inflammatory-diet-for-menopause-what-to-eat) covers the nutritional side, and [why everything aches](/blog/menopause-joint-pain-why-everything-aches-and-what-helps) covers the joint picture.

Recurrent urinary tract infections after menopause are extremely common - and the main cause is not a failing immune system. It is a structural and microbial change in the genitourinary tissue.

The condition is called genitourinary syndrome of menopause (GSM), and it affects a large proportion of postmenopausal women. Estrogen maintains the thickness, elasticity, and blood supply of the vaginal and urethral tissue. Without it, that tissue thins, becomes more fragile, and - critically - the local microbiome changes.

Here is the mechanism that matters. Vaginal lactobacilli feed on glycogen, which estrogen-rich tissue produces in abundance. These bacteria generate lactic acid, keeping vaginal pH acidic at around 3.8-4.5. That acidity is hostile to *E. coli*, the organism responsible for the large majority of UTIs.

When estrogen falls, glycogen drops, lactobacilli decline, and pH rises toward 6 or 7. *E. coli* from the gut can then colonise the area and ascend the shortened, thinner urethra far more easily.

This matters enormously for treatment, because it points to a fix that is not antibiotics. Local vaginal estrogen - a cream, tablet, or ring - restores tissue quality and the acidic environment. Systemic absorption is minimal, which is why it is generally considered appropriate even for many women who cannot or prefer not to take systemic hormone therapy, though this always warrants an individual discussion. Multiple trials have shown it substantially reduces recurrent UTI frequency.

Too many women cycle through repeated antibiotic courses for years without anyone mentioning vaginal estrogen. If that is you, it is a reasonable thing to raise directly. Our guide to [vaginal dryness and GSM](/blog/menopause-vaginal-dryness-gsm-why-it-happens-and-what-helps) covers the wider picture.

One caution: UTIs in older women can present atypically - as confusion, new incontinence, or fatigue rather than burning. Do not assume no burning means no infection.

The evidence-backed levers are not exotic. They are the ones that are easy to dismiss precisely because they are familiar.

1. Sleep, above everything else. Sleep deprivation measurably suppresses immune function. In a well-known experiment, adults who slept less than seven hours a night were substantially more likely to develop a cold after controlled exposure to rhinovirus than those sleeping eight hours or more (Prather et al., *Sleep* 2015). Natural killer cell activity, T cell function, and vaccine response all decline with insufficient sleep. Menopausal insomnia and night sweats therefore have a direct immune cost - which makes treating them a health intervention rather than a comfort measure. See [menopause insomnia and what helps](/blog/menopause-insomnia-why-you-cant-sleep-and-what-helps).

2. Protein. Antibodies are proteins. So are the enzymes and signalling molecules immune cells depend on. Chronic under-eating of protein - common in midlife women, and more common still on appetite-suppressing medication - impairs immune function. Aim for roughly 1.2-1.6 g per kg of body weight daily; [protein in menopause](/blog/protein-in-menopause-how-much-to-prevent-muscle-loss) breaks this down.

3. Vitamin D. Immune cells express the vitamin D receptor, and deficiency is associated with increased respiratory infection risk. A large meta-analysis found supplementation reduced acute respiratory infections, with the clearest benefit in those who were deficient to begin with (Martineau et al., *BMJ* 2017). Get a level checked rather than guessing.

4. Resistance training. Exercise has anti-inflammatory effects at moderate doses, and muscle acts as an endocrine organ releasing myokines that regulate inflammation. Two to three sessions weekly is the target.

5. Fibre and gut health. Around 70% of immune tissue sits in the gut. Fibre feeds the bacteria producing short-chain fatty acids that regulate immune function. Most women eat well under the 30 g daily target - see [menopause and gut health](/blog/menopause-gut-health-why-digestion-changes-and-what-helps).

6. Vaccines. Response may be somewhat blunted after menopause, but vaccination remains clearly effective. Shingles vaccination in particular is worth discussing from age 50.

The evidence points in a favourable direction, but it is not strong enough to prescribe hormone therapy for immune reasons alone.

What we can say with reasonable confidence is that hormone therapy reduces markers of inflammation in some studies, and that transdermal estrogen appears more favourable than oral in this respect. Oral estrogen passes through the liver first, which raises CRP through a first-pass hepatic effect - a rise that reflects liver protein synthesis rather than genuine systemic inflammation, but which complicates interpreting the marker. Patches and gels bypass this. Our comparison of [patch, pill, and gel](/blog/hrt-patch-vs-pill-vs-gel-which-is-safest) explains the delivery differences.

The area where evidence is genuinely solid is local vaginal estrogen for recurrent UTIs, discussed above. That is a well-supported, targeted use.

For systemic immunity - fewer colds, better vaccine responses, less frequent infection - the human data are limited and mixed. Studies are largely observational, use different preparations, and enrol women at very different stages. Nobody has run a large randomised trial with infection rates as the primary endpoint, and nobody is likely to.

What this means practically: if you are considering hormone therapy for hot flushes, sleep disruption, mood, bone, or genitourinary symptoms, any immune or inflammatory benefit is a reasonable bonus to factor in. If your only concern is that you seem to catch every cold going round, HRT is not the obvious first move. Sleep, protein, vitamin D status, and training are.

It is also worth noting that autoimmune conditions respond unpredictably to menopause and to hormone therapy. Rheumatoid arthritis often improves during pregnancy and can worsen after menopause. Lupus may flare with estrogen in some women. If you have an autoimmune diagnosis, this is a conversation for your specialist rather than a general guideline.

The most important thing this article can do is discourage you from attributing everything to menopause. Hormones explain a great deal in midlife. They do not explain everything, and the assumption that they do delays diagnoses.

Book an appointment if you notice:

• •More than three or four significant infections a year requiring antibiotics
• •Recurrent UTIs - three or more in a year, or two in six months
• •Infections that will not resolve or that keep returning to the same site
• •Unexplained fevers, night sweats that are drenching and unrelated to hot flushes, or unintended weight loss
• •Persistent swollen lymph nodes lasting more than a few weeks
• •New joint swelling, rashes, mouth ulcers, or dry eyes and mouth - these can signal autoimmune disease, which frequently first presents in midlife
• •Extreme fatigue that is out of proportion to your sleep and does not improve with rest

That last cluster deserves emphasis. Conditions like Sjogren's syndrome, rheumatoid arthritis, lupus, and autoimmune thyroid disease disproportionately begin in women between 40 and 60 - exactly when symptoms are most likely to be waved through as menopausal. Dry eyes, joint aches, and fatigue are on the menopause symptom list and are also the classic opening presentation of several autoimmune diseases.

Reasonable tests to ask about if infections are genuinely frequent: full blood count, immunoglobulin levels, HbA1c or fasting glucose (undiagnosed diabetes impairs immunity and often appears in this age group), thyroid function, vitamin D, ferritin, and B12. If autoimmune features are present, inflammatory markers and autoantibody screening.

Most women who feel run-down in midlife have a combination of poor sleep, inadequate protein, low vitamin D, and genuine hormonal change - all addressable. But it is worth confirming that rather than assuming it. Ask the question and get the blood test. Being told it is hormonal after investigation is very different from being told it is hormonal instead of one.